Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plasmodium falciparum | 18 | 2013 | 135 | 2.020 |
Why?
|
| Merozoite Surface Protein 1 | 8 | 2010 | 35 | 0.890 |
Why?
|
| Malaria, Falciparum | 6 | 2013 | 90 | 0.890 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2022 | 4 | 0.860 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2022 | 9 | 0.860 |
Why?
|
| Antigens, Protozoan | 12 | 2002 | 72 | 0.760 |
Why?
|
| Antibodies, Protozoan | 12 | 2010 | 79 | 0.700 |
Why?
|
| Health Services, Indigenous | 1 | 2018 | 24 | 0.610 |
Why?
|
| Schools, Medical | 1 | 2018 | 198 | 0.540 |
Why?
|
| Metabolome | 1 | 2013 | 53 | 0.440 |
Why?
|
| Metabolomics | 1 | 2013 | 81 | 0.430 |
Why?
|
| Protozoan Proteins | 5 | 1994 | 182 | 0.430 |
Why?
|
| Erythrocytes | 1 | 2013 | 111 | 0.420 |
Why?
|
| Epitopes | 4 | 2010 | 148 | 0.410 |
Why?
|
| Protein Precursors | 3 | 1994 | 61 | 0.350 |
Why?
|
| Immunoglobulin M | 1 | 2010 | 82 | 0.350 |
Why?
|
| Immunoglobulin G | 1 | 2010 | 237 | 0.320 |
Why?
|
| Malaria Vaccines | 3 | 2010 | 21 | 0.290 |
Why?
|
| Biomedical Research | 2 | 2021 | 400 | 0.260 |
Why?
|
| Minority Groups | 2 | 2021 | 596 | 0.250 |
Why?
|
| Lymphocyte Activation | 2 | 2022 | 236 | 0.250 |
Why?
|
| Adjuvants, Immunologic | 3 | 1994 | 107 | 0.240 |
Why?
|
| Antigens, Surface | 5 | 1994 | 43 | 0.230 |
Why?
|
| Genetic Variation | 1 | 2005 | 387 | 0.220 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2022 | 10 | 0.220 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2022 | 11 | 0.220 |
Why?
|
| Interleukin-4 | 1 | 2022 | 72 | 0.210 |
Why?
|
| Cytokines | 2 | 2022 | 602 | 0.200 |
Why?
|
| Ligands | 1 | 2022 | 349 | 0.190 |
Why?
|
| Peptide Fragments | 2 | 1993 | 308 | 0.190 |
Why?
|
| Humans | 12 | 2022 | 37093 | 0.170 |
Why?
|
| Cross Reactions | 4 | 2010 | 83 | 0.170 |
Why?
|
| Cell Differentiation | 1 | 2022 | 587 | 0.170 |
Why?
|
| Behavioral Research | 1 | 2019 | 39 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 68 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 76 | 0.160 |
Why?
|
| Minority Health | 1 | 2019 | 88 | 0.160 |
Why?
|
| Colombia | 2 | 2010 | 20 | 0.160 |
Why?
|
| Baculoviridae | 3 | 2002 | 14 | 0.150 |
Why?
|
| Recombinant Proteins | 5 | 2010 | 515 | 0.150 |
Why?
|
| Alleles | 3 | 2010 | 321 | 0.130 |
Why?
|
| Genotype | 2 | 2010 | 730 | 0.130 |
Why?
|
| Hawaii | 2 | 2020 | 1929 | 0.130 |
Why?
|
| Major Histocompatibility Complex | 1 | 1994 | 21 | 0.120 |
Why?
|
| Animals | 16 | 2010 | 15081 | 0.120 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2013 | 2 | 0.110 |
Why?
|
| Data Mining | 1 | 2013 | 23 | 0.110 |
Why?
|
| Hydrolysis | 1 | 2013 | 99 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 67 | 0.110 |
Why?
|
| Glycolysis | 1 | 2013 | 68 | 0.110 |
Why?
|
| Arginine | 1 | 2013 | 73 | 0.110 |
Why?
|
| Rabbits | 5 | 2008 | 283 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2013 | 291 | 0.100 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 260 | 0.100 |
Why?
|
| Antibody Specificity | 5 | 2008 | 79 | 0.100 |
Why?
|
| Seeds | 1 | 2010 | 35 | 0.090 |
Why?
|
| Papua New Guinea | 1 | 2010 | 21 | 0.090 |
Why?
|
| Cameroon | 1 | 2010 | 38 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2013 | 928 | 0.090 |
Why?
|
| Child | 2 | 2010 | 3131 | 0.090 |
Why?
|
| Arabidopsis | 1 | 2010 | 95 | 0.090 |
Why?
|
| Gene Frequency | 1 | 2010 | 195 | 0.090 |
Why?
|
| Protozoan Vaccines | 3 | 1994 | 15 | 0.080 |
Why?
|
| Research Personnel | 2 | 2021 | 155 | 0.080 |
Why?
|
| HIV Infections | 1 | 2022 | 2303 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2022 | 1492 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 1994 | 1015 | 0.080 |
Why?
|
| Vaccines, Synthetic | 3 | 2008 | 72 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2008 | 448 | 0.080 |
Why?
|
| Amino Acid Sequence | 6 | 2008 | 1180 | 0.080 |
Why?
|
| Adolescent | 2 | 2010 | 5363 | 0.070 |
Why?
|
| Mice | 7 | 1996 | 5913 | 0.070 |
Why?
|
| Infant | 1 | 2010 | 1046 | 0.070 |
Why?
|
| DNA | 1 | 1988 | 574 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2010 | 1418 | 0.060 |
Why?
|
| Molecular Sequence Data | 5 | 2002 | 1568 | 0.060 |
Why?
|
| Middle Aged | 2 | 2010 | 10129 | 0.060 |
Why?
|
| Antibodies, Bispecific | 1 | 2002 | 3 | 0.050 |
Why?
|
| Granulocytes | 1 | 2022 | 29 | 0.050 |
Why?
|
| Immune Sera | 3 | 1992 | 59 | 0.050 |
Why?
|
| Adult | 2 | 2010 | 11712 | 0.050 |
Why?
|
| Actins | 1 | 2022 | 148 | 0.050 |
Why?
|
| Mice, Inbred Strains | 2 | 1994 | 116 | 0.050 |
Why?
|
| Fibrosis | 1 | 2022 | 159 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 1996 | 290 | 0.050 |
Why?
|
| Maryland | 1 | 2021 | 53 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 26 | 0.050 |
Why?
|
| Phenotype | 1 | 2022 | 689 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 357 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2020 | 109 | 0.040 |
Why?
|
| Young Adult | 1 | 2010 | 4268 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 1992 | 1609 | 0.040 |
Why?
|
| Male | 2 | 2010 | 20025 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2019 | 80 | 0.040 |
Why?
|
| Species Specificity | 2 | 1989 | 245 | 0.040 |
Why?
|
| Female | 2 | 2010 | 20969 | 0.040 |
Why?
|
| Base Sequence | 2 | 1992 | 997 | 0.040 |
Why?
|
| Aged | 1 | 2010 | 6741 | 0.040 |
Why?
|
| Inflammation | 1 | 2022 | 618 | 0.040 |
Why?
|
| Cultural Diversity | 1 | 2019 | 169 | 0.040 |
Why?
|
| Immunization | 2 | 1992 | 92 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 2721 | 0.030 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1994 | 42 | 0.030 |
Why?
|
| Immunoblotting | 2 | 1996 | 176 | 0.030 |
Why?
|
| Primates | 1 | 1994 | 36 | 0.030 |
Why?
|
| Haplotypes | 1 | 1994 | 182 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2019 | 642 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1992 | 24 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1992 | 22 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 1993 | 185 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 90 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1992 | 111 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 1992 | 93 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1992 | 189 | 0.030 |
Why?
|
| Acetylmuramyl-Alanyl-Isoglutamine | 1 | 1991 | 1 | 0.020 |
Why?
|
| Lipid A | 1 | 1991 | 7 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 1991 | 14 | 0.020 |
Why?
|
| Hybridomas | 2 | 2002 | 29 | 0.020 |
Why?
|
| Vaccination | 1 | 1992 | 288 | 0.020 |
Why?
|
| Blotting, Western | 1 | 1992 | 859 | 0.020 |
Why?
|
| Antibody Formation | 1 | 1989 | 74 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1989 | 201 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1988 | 45 | 0.020 |
Why?
|
| Vaccines, Subunit | 1 | 2008 | 30 | 0.020 |
Why?
|
| United States | 1 | 2019 | 4223 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1988 | 49 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2008 | 99 | 0.020 |
Why?
|
| Vaccines | 1 | 1988 | 55 | 0.020 |
Why?
|
| Malaria | 1 | 1988 | 78 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1988 | 191 | 0.020 |
Why?
|
| Water | 1 | 1988 | 296 | 0.020 |
Why?
|
| Muromonab-CD3 | 1 | 2002 | 2 | 0.010 |
Why?
|
| Neutrophil Activation | 1 | 2002 | 4 | 0.010 |
Why?
|
| Single-Chain Antibodies | 1 | 2002 | 3 | 0.010 |
Why?
|
| Spodoptera | 1 | 2002 | 13 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2002 | 25 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2002 | 69 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 2002 | 56 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 92 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2002 | 250 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 523 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 356 | 0.010 |
Why?
|
| Cell Line | 1 | 2002 | 1354 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1996 | 35 | 0.010 |
Why?
|
| Antibody Affinity | 1 | 1991 | 25 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 1991 | 211 | 0.010 |
Why?
|
| Peptides | 1 | 1991 | 320 | 0.010 |
Why?
|